BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murugan AK. mTOR: Role in cancer, metastasis and drug resistance. Semin Cancer Biol 2019;59:92-111. [PMID: 31408724 DOI: 10.1016/j.semcancer.2019.07.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 74] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Popova NV, Jücker M. The Role of mTOR Signaling as a Therapeutic Target in Cancer. Int J Mol Sci 2021;22:1743. [PMID: 33572326 DOI: 10.3390/ijms22041743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
2 Li Z, Zheng J, Feng Y, Li Y, Liang Y, Liu Y, Wang X, Yang Q. Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer. Cancer Med 2021;10:7877-92. [PMID: 34581026 DOI: 10.1002/cam4.4291] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ma C, Li F, Wang Z, Luo H, Suda K. A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/4995874] [Reference Citation Analysis]
4 Peng Q, Cheng M, Li T, Chen X, Shen Y, Zhu Y, Xu B. Integrated characterization and validation of the prognostic significance of microRNA-200s in colorectal cancer. Cancer Cell Int 2020;20:56. [PMID: 32099529 DOI: 10.1186/s12935-020-1142-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhong W, Darmani NA. Role of PI3K/Akt/GSK-3 Pathway in Emesis and Potential New Antiemetics. J Cell Signal 2020;1:155-9. [PMID: 33426544 DOI: 10.33696/Signaling.1.024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Cuomo F, Altucci L, Cobellis G. Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy. Cancers (Basel) 2019;11:E1465. [PMID: 31569540 DOI: 10.3390/cancers11101465] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
7 Li T, Kuang T, Yang Z, Zhang Q, Zhang W, Fan Y. Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein. Front Cell Dev Biol 2021;9:633035. [PMID: 34540820 DOI: 10.3389/fcell.2021.633035] [Reference Citation Analysis]
8 Mu X, Shen Z, Lin Y, Xiao J, Xia K, Xu C, Chen B, Shi R, Zhu A, Sun X, Tao T, Song X, Xuan Q, Zhao Y. LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/8693259] [Reference Citation Analysis]
9 Mi X, Lai K, Yan L, Xie S, Qiu X, Xiao S, Wei S. miR-18a expression in basal cell carcinoma and regulatory mechanism on autophagy through mTOR pathway. Clin Exp Dermatol 2020;45:1027-34. [PMID: 32485050 DOI: 10.1111/ced.14322] [Reference Citation Analysis]
10 Yiğit SE, Gökmen İB, Okuturlar Y. Ground Glass Appearance During the Pandemic Period: Everolimus Induced Interstitial Pneumonia. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.1078775] [Reference Citation Analysis]
11 Tlili H, Macovei A, Buonocore D, Lanzafame M, Najjaa H, Lombardi A, Pagano A, Dossena M, Verri M, Arfa AB, Neffati M, Doria E. The polyphenol/saponin-rich Rhus tripartita extract has an apoptotic effect on THP-1 cells through the PI3K/AKT/mTOR signaling pathway. BMC Complement Med Ther 2021;21:153. [PMID: 34044827 DOI: 10.1186/s12906-021-03328-9] [Reference Citation Analysis]
12 Zhang N, Wang Z, Lv J, Zhang S, Liu Y, Liu T, Li W, Gong L, Zhang X, El-omar EM, Lu W. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion. Front Med 2022;9:836369. [DOI: 10.3389/fmed.2022.836369] [Reference Citation Analysis]
13 Wu S, Yan M, Ge R, Cheng CY. Crosstalk between Sertoli and Germ Cells in Male Fertility. Trends Mol Med 2020;26:215-31. [PMID: 31727542 DOI: 10.1016/j.molmed.2019.09.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
14 Yao Z, Wen S, Luo J, Hao W, Liang W, Chen Y. Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma. Biomed Res Int 2021;2021:6299472. [PMID: 34853791 DOI: 10.1155/2021/6299472] [Reference Citation Analysis]
15 Shen M, Li X, Qian B, Wang Q, Lin S, Wu W, Zhu S, Zhu R, Zhao S. Crucial Roles of microRNA-Mediated Autophagy in Urologic Malignancies. Int J Biol Sci 2021;17:3356-68. [PMID: 34512152 DOI: 10.7150/ijbs.61175] [Reference Citation Analysis]
16 Gureev AP, Sadovnikova IS, Starkov NN, Starkov AA, Popov VN. p62-Nrf2-p62 Mitophagy Regulatory Loop as a Target for Preventive Therapy of Neurodegenerative Diseases. Brain Sci 2020;10:E847. [PMID: 33198234 DOI: 10.3390/brainsci10110847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mobet Y, Liu X, Liu T, Yu J, Yi P. Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer. Front Cell Dev Biol 2022;10:813581. [DOI: 10.3389/fcell.2022.813581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Lashgari NA, Roudsari NM, Momtaz S, Abdolghaffari AH. Mammalian target of rapamycin-novel insight for management of inflammatory bowel diseases. World J Pharmacol 2022; 11(1): 1-5 [DOI: 10.5497/wjp.v11.i1.1] [Reference Citation Analysis]
19 Peñailillo J, Palacios M, Mounieres C, Muñoz R, Slater PG, De Domenico E, Patrushev I, Gilchrist M, Larraín J. Analysis of the early response to spinal cord injury identified a key role for mTORC1 signaling in the activation of neural stem progenitor cells. NPJ Regen Med 2021;6:68. [PMID: 34686684 DOI: 10.1038/s41536-021-00179-3] [Reference Citation Analysis]
20 Alves ALV, Costa AM, Martinho O, da Silva VD, Jordan P, Silva VAO, Reis RM. WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell Line. Cells 2020;9:E485. [PMID: 32093151 DOI: 10.3390/cells9020485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, Ranieri E. The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. Cancers (Basel) 2021;13:3949. [PMID: 34439105 DOI: 10.3390/cancers13163949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
22 Lawal B, Lee CY, Mokgautsi N, Sumitra MR, Khedkar H, Wu ATH, Huang HS. mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications. Front Oncol 2021;11:656738. [PMID: 33842373 DOI: 10.3389/fonc.2021.656738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
23 Chang L, Zhang Y, Li M, Zhao X, Wang D, Liu J, Zhou F, Zhang J. Nanostructured lipid carrier co-delivering paclitaxel and doxorubicin restrains the proliferation and promotes apoptosis of glioma stem cells via regulating PI3K/Akt/mTOR signaling. Nanotechnology 2021;32:225101. [PMID: 33690190 DOI: 10.1088/1361-6528/abd439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yu C, Wu Y, Hu K, Zhang S, Imran A. Prominin 1 Significantly Correlated with Bone Metastasis of Breast Cancer and Influenced the Patient’s Prognosis. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/4123622] [Reference Citation Analysis]
25 Ma H, Liu C, Zhang S, Yuan W, Hu J, Huang D, Zhang X, Liu Y, Qiu Y. miR-328-3p promotes migration and invasion by targeting H2AFX in head and neck squamous cell carcinoma. J Cancer 2021;12:6519-30. [PMID: 34659543 DOI: 10.7150/jca.60743] [Reference Citation Analysis]
26 Mortezaee K, Najafi M. Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives. Crit Rev Oncol Hematol 2021;157:103180. [PMID: 33264717 DOI: 10.1016/j.critrevonc.2020.103180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
27 Wei Z, Liu X, Cheng C, Yu W, Yi P. Metabolism of Amino Acids in Cancer. Front Cell Dev Biol 2020;8:603837. [PMID: 33511116 DOI: 10.3389/fcell.2020.603837] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
28 Shi Y, Wang X, Wang J, Wang X, Zhou H, Zhang L. The dual roles of A20 in cancer. Cancer Lett 2021;511:26-35. [PMID: 33933552 DOI: 10.1016/j.canlet.2021.04.017] [Reference Citation Analysis]
29 Duan T, Zhou D, Yao Y, Shao X. The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer. Front Oncol 2021;11:706838. [PMID: 34552869 DOI: 10.3389/fonc.2021.706838] [Reference Citation Analysis]
30 Lin R, Xu Y, Xie S, Zhang Y, Wang H, Yi G, Huang G, Ni B, Song H, Wang Z, Qi S, Liu Y. Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma. J Neurooncol. [DOI: 10.1007/s11060-022-03964-2] [Reference Citation Analysis]
31 Li HW, Liu MB, Jiang X, Song T, Feng SX, Wu JY, Deng PF, Wang XY. GALNT14 regulates ferroptosis and apoptosis of ovarian cancer through the EGFR/mTOR pathway. Future Oncol 2021. [PMID: 34643088 DOI: 10.2217/fon-2021-0883] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
32 Chi OZ, Liu X, Cofano S, Patel N, Jacinto E, Weiss HR. Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption. Front Physiol 2021;12:706528. [PMID: 34354602 DOI: 10.3389/fphys.2021.706528] [Reference Citation Analysis]
33 Qu J, Luo M, Zhang J, Han F, Hou N, Pan R, Sun X. A paradoxical role for sestrin 2 protein in tumor suppression and tumorigenesis. Cancer Cell Int 2021;21:606. [PMID: 34784907 DOI: 10.1186/s12935-021-02317-9] [Reference Citation Analysis]
34 Zhao Y, Song Y, Zhao R, Zhao M, Huang Q. Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation. Front Oncol 2020;10:607727. [PMID: 33330109 DOI: 10.3389/fonc.2020.607727] [Reference Citation Analysis]
35 Yasuda T, Ishikawa T, Hirose R, Doi T, Inoue K, Dohi O, Yoshida N, Kamada K, Uchiyama K, Takagi T, Konishi H, Inamori O, Morinaga Y, Konishi E, Naito Y, Itoh Y. Aggressive advanced gastric cancer in a patient with autosomal dominant polycystic kidney disease. Clin J Gastroenterol 2021;14:1014-9. [PMID: 34028786 DOI: 10.1007/s12328-021-01407-5] [Reference Citation Analysis]
36 Liu Y, Qi X, Zhao Z, Song D, Wang L, Zhai Q, Zhang X, Zhao P, Xiang X. TIPE1-mediated autophagy suppression promotes nasopharyngeal carcinoma cell proliferation via the AMPK/mTOR signalling pathway. J Cell Mol Med 2020;24:9135-44. [PMID: 32588529 DOI: 10.1111/jcmm.15550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Magaway C, Kim E, Jacinto E. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations. Cells 2019;8:E1584. [PMID: 31817676 DOI: 10.3390/cells8121584] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
38 Guenzle J, Akasaka H, Joechle K, Reichardt W, Venkatasamy A, Hoeppner J, Hellerbrand C, Fichtner-Feigl S, Lang SA. Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. Int J Mol Sci 2020;22:E30. [PMID: 33375117 DOI: 10.3390/ijms22010030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Zhang Y, Shi X, Xie X, Laster KV, Pang M, Liu K, Hwang J, Kim DJ. Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR. Phytother Res 2021. [PMID: 34545650 DOI: 10.1002/ptr.7289] [Reference Citation Analysis]
40 Iksen, Pothongsrisit S, Pongrakhananon V. Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products. Molecules 2021;26:4100. [PMID: 34279440 DOI: 10.3390/molecules26134100] [Reference Citation Analysis]
41 Yang R, Ma M, Yu S, Li X, Zhang J, Wu S. High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer. Front Oncol 2021;11:742017. [PMID: 34671559 DOI: 10.3389/fonc.2021.742017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Liu Z, Yang J, Chen Y, Chen C, Wang J, Lee YM, Zheng W, Shang R, Tang Y, Zhang X, Hu X, Huang Y, Peng S, Liou YC, He W, Luo G. P311 Facilitates the Angiogenesis and Wound Healing Function of MSCs by Increasing VEGF Production. Front Immunol 2022;13:821932. [PMID: 35154140 DOI: 10.3389/fimmu.2022.821932] [Reference Citation Analysis]
43 Sun Y, Berleth N, Wu W, Schlütermann D, Deitersen J, Stuhldreier F, Berning L, Friedrich A, Akgün S, Mendiburo MJ, Wesselborg S, Conrad M, Berndt C, Stork B. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death Dis 2021;12:1028. [PMID: 34716292 DOI: 10.1038/s41419-021-04306-2] [Reference Citation Analysis]
44 Li Y, Xiao X, Wang H, Zhou Q, Jin Z, Zhang Y, Wang Y, Yue F, Zhou S, Yang J. Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling. Eur J Pharmacol 2021;909:174411. [PMID: 34390710 DOI: 10.1016/j.ejphar.2021.174411] [Reference Citation Analysis]
45 Xu LL, Shang Y, Qu XN, He HM. M-Phase Phosphoprotein 9 upregulation associates with poor prognosis and activates mTOR signaling in gastric cancer. Kaohsiung J Med Sci 2021;37:208-14. [PMID: 33174370 DOI: 10.1002/kjm2.12319] [Reference Citation Analysis]
46 Zhang CQ, Yi S, Chen BB, Cui PP, Wang Y, Li YZ. mTOR/NF-κB signaling pathway protects hippocampal neurons from injury induced by intermittent hypoxia in rats. Int J Neurosci 2021;131:994-1003. [PMID: 32378972 DOI: 10.1080/00207454.2020.1766460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Zhao D, Huang X, Zhang Z, Ding J, Cui Y, Chen X. Engineered nanomedicines for tumor vasculature blockade therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1691. [PMID: 33480163 DOI: 10.1002/wnan.1691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Che X, Qi X, Xu Y, Wang Q, Wu G. Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance. Oxid Med Cell Longev 2021;2021:6613151. [PMID: 34194607 DOI: 10.1155/2021/6613151] [Reference Citation Analysis]
49 Zhang X, Li Q, Du A, Li Y, Shi Q, Chen Y, Zhao Y, Wang B, Pan F. Adipocytic Glutamine Synthetase Upregulation via Altered Histone Methylation Promotes 5FU Chemoresistance in Peritoneal Carcinomatosis of Colorectal Cancer. Front Oncol 2021;11:748730. [PMID: 34712612 DOI: 10.3389/fonc.2021.748730] [Reference Citation Analysis]
50 Bryant JP, Levy A, Heiss J, Banasavadi-Siddegowda YK. Review of PP2A Tumor Biology and Antitumor Effects of PP2A Inhibitor LB100 in the Nervous System. Cancers (Basel) 2021;13:3087. [PMID: 34205611 DOI: 10.3390/cancers13123087] [Reference Citation Analysis]
51 El Hage A, Dormond O. Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment. Cancers (Basel) 2021;13:1359. [PMID: 33802831 DOI: 10.3390/cancers13061359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Pan Y, Tang H, Li Q, Chen G, Li D. Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Med 2022. [PMID: 35587712 DOI: 10.1002/cam4.4830] [Reference Citation Analysis]
53 Huan J, Grivas P, Birch J, Hansel DE. Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy. Cancers 2022;14:1555. [DOI: 10.3390/cancers14061555] [Reference Citation Analysis]
54 Zhang J, Wang X, Li G, He J, Lu Z, Yang Y, Jiang Y, Jiang L, Li F, Liu J. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC. Biomed Res Int 2021;2021:6648078. [PMID: 33824874 DOI: 10.1155/2021/6648078] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Pelizzaro F, Gambato M, Gringeri E, Vitale A, Cillo U, Farinati F, Burra P, Russo FP. Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers (Basel) 2021;13:4882. [PMID: 34638365 DOI: 10.3390/cancers13194882] [Reference Citation Analysis]
56 Feng N, Wang B, Cai P, Zheng W, Zou H, Gu J, Yuan Y, Liu X, Liu Z, Bian J. ZEA-induced autophagy in TM4 cells was mediated by the release of Ca2+ activates CaMKKβ-AMPK signaling pathway in the endoplasmic reticulum. Toxicol Lett 2020;323:1-9. [PMID: 31982503 DOI: 10.1016/j.toxlet.2020.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
57 Maldonado G, Hernández G. Translational control in the naked mole-rat as a model highly resistant to cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188455. [PMID: 33148499 DOI: 10.1016/j.bbcan.2020.188455] [Reference Citation Analysis]
58 Yu S, Hu Q, Fan K, Yang C, Gao Y. CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling. J Cell Commun Signal 2021;15:383-92. [PMID: 33928514 DOI: 10.1007/s12079-021-00619-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Chagas PF, Baroni M, Brassesco MS, Tone LG. Interplay between the RNA binding‐protein Musashi and developmental signaling pathways. J Gene Med 2020;22. [DOI: 10.1002/jgm.3136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Tian L, Chen C, Guo Y, Zhang F, Mi J, Feng Q, Lin S, Xi N, Tian J, Yu L, Chen Y, Cao M, Lai C, Fan J, Zhang Y, Chen G. mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer. Neoplasia 2021;23:643-52. [PMID: 34126361 DOI: 10.1016/j.neo.2021.05.007] [Reference Citation Analysis]
61 Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Front Chem 2020;8:829. [PMID: 33195038 DOI: 10.3389/fchem.2020.00829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
62 Alammar H, Nassani R, Alshehri MM, Aljohani AA, Alrfaei BM. Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review. Int J Mol Sci 2021;23:464. [PMID: 35008889 DOI: 10.3390/ijms23010464] [Reference Citation Analysis]
63 Lu J, Qian J, Xu Z, Yin S, Zhou L, Zheng S, Zhang W. Emerging Roles of Liquid-Liquid Phase Separation in Cancer: From Protein Aggregation to Immune-Associated Signaling. Front Cell Dev Biol 2021;9:631486. [PMID: 34235141 DOI: 10.3389/fcell.2021.631486] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Yong CQY, Tang BL. Cancer-driving mutations and variants of components of the membrane trafficking core machinery. Life Sci 2021;264:118662. [PMID: 33127517 DOI: 10.1016/j.lfs.2020.118662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Wang X, Dou X, Ren X, Rong Z, Sun L, Deng Y, Chen P, Li Z. A Ductal-Cell-Related Risk Model Integrating Single-Cell and Bulk Sequencing Data Predicts the Prognosis of Patients With Pancreatic Adenocarcinoma. Front Genet 2021;12:763636. [PMID: 35047000 DOI: 10.3389/fgene.2021.763636] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Su W, Feng B, Hu L, Guo X, Yu M. MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09709-8] [Reference Citation Analysis]
67 Borges GA, Elias ST, Amorim B, de Lima CL, Coletta RD, Castilho RM, Squarize CH, Guerra ENS. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells. Phytother Res 2020;34:3311-24. [PMID: 32628350 DOI: 10.1002/ptr.6780] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
68 Xu F, Na L, Li Y, Chen L. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 2020;10:54. [PMID: 32266056 DOI: 10.1186/s13578-020-00416-0] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 52.0] [Reference Citation Analysis]
69 He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. Targeting PI3K/Akt signal transduction for cancer therapy. Sig Transduct Target Ther 2021;6. [DOI: 10.1038/s41392-021-00828-5] [Reference Citation Analysis]
70 Liu Y, Wang S, Zhou R, Li W, Zhang G. Overexpression of E74-like transformation-specific transcription factor 3 promotes cellular proliferation and predicts poor prognosis in ovarian cancer. Oncol Lett 2021;22:710. [PMID: 34457065 DOI: 10.3892/ol.2021.12971] [Reference Citation Analysis]
71 Liao H, Wang Y, Xu X, Zhou C, Zhang J, Zhong K, Yang D. [The dual mTORC1/2 inhibitor AZD2014 inhibits acute graft rejection in a rat liver transplantation model]. Nan Fang Yi Ke Da Xue Xue Bao 2022;42:598-603. [PMID: 35527497 DOI: 10.12122/j.issn.1673-4254.2022.04.17] [Reference Citation Analysis]
72 Liu J, Hu X, Feng L, Lin Y, Liang S, Zhu Z, Shi S, Dong C. Carbonic anhydrase IX-targeted H-APBC nanosystem combined with phototherapy facilitates the efficacy of PI3K/mTOR inhibitor and resists HIF-1α-dependent tumor hypoxia adaptation. J Nanobiotechnology 2022;20:187. [PMID: 35413842 DOI: 10.1186/s12951-022-01394-w] [Reference Citation Analysis]
73 Shi J, Wang K, Xiong Z, Yuan C, Wang C, Cao Q, Yu H, Meng X, Xie K, Cheng Z, Yang H, Chen K, Zhang X. Impact of inflammation and immunotherapy in renal cell carcinoma. Oncol Lett 2020;20:272. [PMID: 33014151 DOI: 10.3892/ol.2020.12135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Zhang A, Yang J, Ma C, Li F, Luo H. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma. Front Cell Dev Biol 2021;9:616271. [PMID: 34249899 DOI: 10.3389/fcell.2021.616271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Murugan AK, Alzahrani AS. Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas. Br J Biomed Sci 2022;79:10208. [DOI: 10.3389/bjbs.2021.10208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Papaefthymiou A, Christodoulidis G, Koffas A, Doulberis M, Polyzos SA, Manolakis A, Potamianos S, Kapsoritakis A, Kountouras J. Role of autophagy in gastric carcinogenesis. World J Gastrointest Oncol 2021; 13(10): 1244-1262 [PMID: 34721765 DOI: 10.4251/wjgo.v13.i10.1244] [Reference Citation Analysis]
77 Rehan M, Shafiullah, Sultanat. Cytotoxicity of oleanane type triterpene from leaf extract of Pterospermum acerifolium (in vitro) and theoretical investigation of inhibitory signaling pathway. Chinese Herbal Medicines 2021;13:124-30. [DOI: 10.1016/j.chmed.2020.09.004] [Reference Citation Analysis]
78 Tseng YH, Yang RC, Chiou SS, Shieh TM, Shih YH, Lin PC. Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells. Mol Med Rep 2021;24:565. [PMID: 34109436 DOI: 10.3892/mmr.2021.12204] [Reference Citation Analysis]
79 Du L, Wang D, Nagle PW, Groen AAH, Zhang H, Muijs CT, Plukker JTM, Coppes RP. Role of mTOR through Autophagy in Esophageal Cancer Stemness. Cancers 2022;14:1806. [DOI: 10.3390/cancers14071806] [Reference Citation Analysis]
80 Chou CH, Wang HK, Lin YC, Tsai DH, Lu MT, Ho CT, Hseu YC, Yang HL, Way TD. Bisdemethoxycurcumin Promotes Apoptosis and Inhibits the Epithelial-Mesenchymal Transition through the Inhibition of the G-Protein-Coupled Receptor 161/Mammalian Target of Rapamycin Signaling Pathway in Triple Negative Breast Cancer Cells. J Agric Food Chem 2021;69:14557-67. [PMID: 34813306 DOI: 10.1021/acs.jafc.1c05585] [Reference Citation Analysis]
81 Shen Y, Dai X, Chen H, Zhai S, Peng Q, Cai S, Zhu Y, Huan J, Shen Y. Comprehensive evaluation of microRNA-10b in digestive system cancers reveals prognostic implication and signaling pathways associated with tumor progression. J Cancer 2021;12:4011-24. [PMID: 34093806 DOI: 10.7150/jca.51303] [Reference Citation Analysis]
82 Cao RZ, Min L, Liu S, Tian RY, Jiang HY, Liu J, Shao LL, Cheng R, Zhu ST, Guo SL, Li P. Rictor Activates Cav 1 Through the Akt Signaling Pathway to Inhibit the Apoptosis of Gastric Cancer Cells. Front Oncol 2021;11:641453. [PMID: 34540654 DOI: 10.3389/fonc.2021.641453] [Reference Citation Analysis]
83 Gao T, Liu X, He B, Pan Y, Wang S. IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy. Aging (Albany NY) 2020;12:21236-52. [PMID: 33173015 DOI: 10.18632/aging.103837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Xu JL, Yuan L, Tang YC, Xu ZY, Xu HD, Cheng XD, Qin JJ. The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe? Front Cell Dev Biol 2020;8:621428. [PMID: 33344463 DOI: 10.3389/fcell.2020.621428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
85 Fan Q, Wu Y, Li M, An F, Yao L, Wang M, Wang X, Yuan J, Jiang K, Li W, Li M. Lactobacillus spp. create a protective micro-ecological environment through regulating the core fucosylation of vaginal epithelial cells against cervical cancer. Cell Death Dis 2021;12:1094. [PMID: 34799549 DOI: 10.1038/s41419-021-04388-y] [Reference Citation Analysis]
86 Xu L, Zhang L, Zhang X, Li G, Wang Y, Dong J, Wang H, Hu Z, Cao X, Zhang S, Shi F. HDAC6 Negatively Regulates miR-155-5p Expression to Elicit Proliferation by Targeting RHEB in Microvascular Endothelial Cells under Mechanical Unloading. Int J Mol Sci 2021;22:10527. [PMID: 34638868 DOI: 10.3390/ijms221910527] [Reference Citation Analysis]
87 Chi OZ, Theis T, Kumar S, Chiricolo A, Liu X, Farooq S, Trivedi N, Young W, Schachner M, Weiss HR. Adhesion molecule L1 inhibition increases infarct size in cerebral ischemia-reperfusion without change in blood-brain barrier disruption. Neurol Res 2021;43:751-9. [PMID: 34057049 DOI: 10.1080/01616412.2021.1934311] [Reference Citation Analysis]
88 Mou Q, Yao K, Ye M, Zhao B, Hu Y, Lou X, Li H, Zhang H, Zhao Y. Modulation of Sirt1-mTORC1 Pathway in Microglia Attenuates Retinal Ganglion Cell Loss After Optic Nerve Injury. J Inflamm Res 2021;14:6857-69. [PMID: 34934336 DOI: 10.2147/JIR.S338815] [Reference Citation Analysis]
89 Ma X, Li Y. Circ_0028007 Aggravates the Malignancy of Nasopharyngeal Carcinoma by Regulating miR-656-3p/ELF2 Axis. Biochem Genet 2022. [PMID: 35239093 DOI: 10.1007/s10528-022-10205-8] [Reference Citation Analysis]
90 Xin M, Gao Q, Xiang X, Xu J, Jiao Y, Li X, Zhang X, Jia X. Autophagy Inhibition Enhances the Anti-Tumor Activity of Methylseleninic Acid in Cisplatin-Resistance Human Lung Adenocarcinoma Cells. Front Pharmacol 2022;13:890974. [PMID: 35592418 DOI: 10.3389/fphar.2022.890974] [Reference Citation Analysis]
91 Cao D, Ge S, Li M. MiR-451a Promotes Cell Growth, Migration and EMT in Osteosarcoma by Regulating YTHDC1-mediated m6A Methylation to Activate the AKT/mTOR Signaling Pathway. Journal of Bone Oncology 2022. [DOI: 10.1016/j.jbo.2022.100412] [Reference Citation Analysis]
92 Qi H, Wang L, Zhang M, Wang Z, Gao X, Li M. Methionine and leucine induce ARID1A degradation to promote mTOR expression and milk synthesis in mammary epithelial cells. J Nutr Biochem 2021;101:108924. [PMID: 34843932 DOI: 10.1016/j.jnutbio.2021.108924] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Front Oncol 2022;12:819128. [DOI: 10.3389/fonc.2022.819128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
94 Mirzaei S, Gholami MH, Mahabady MK, Nabavi N, Zabolian A, Banihashemi SM, Haddadi A, Entezari M, Hushmandi K, Makvandi P, Samarghandian S, Zarrabi A, Ashrafizadeh M, Khan H. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. Biomed Pharmacother 2021;133:111077. [PMID: 33378975 DOI: 10.1016/j.biopha.2020.111077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
95 Zhuang W, Dong X, Wang B, Liu N, Guo H, Zhang C, Gan W. NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells. Oncol Lett 2021;22:679. [PMID: 34345304 DOI: 10.3892/ol.2021.12940] [Reference Citation Analysis]
96 Zhang L, Li M, Wang Z, Sun P, Wei S, Zhang C, Wu H, Bai H. Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis. Front Immunol 2021;12:780804. [PMID: 35069552 DOI: 10.3389/fimmu.2021.780804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
97 Parate S, Kumar V, Hong JC, Lee KW. Putative dual inhibitors of mTOR and RET kinase from natural products: Pharmacophore-based hierarchical virtual screening. Journal of Molecular Liquids 2022;350:118562. [DOI: 10.1016/j.molliq.2022.118562] [Reference Citation Analysis]
98 Yiğit SE, Gökmen İB, Okuturlar Y. Pembrolizumab Induced Hypothyroidism: A Case Report. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.1078792] [Reference Citation Analysis]
99 Dent P, Booth L, Poklepovic A, Hancock JF. Signaling alterations caused by drugs and autophagy. Cell Signal 2019;64:109416. [PMID: 31520735 DOI: 10.1016/j.cellsig.2019.109416] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
100 Lan J, Huang J, Tao X, Gao Y, Zhang L, Huang W, Luo J, Liu C, Deng Y, Liu L, Liu X. Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways. J Cell Mol Med 2022. [PMID: 35322916 DOI: 10.1111/jcmm.17278] [Reference Citation Analysis]
101 Korbecki J, Olbromski M, Dzięgiel P. CCL18 in the Progression of Cancer. Int J Mol Sci 2020;21:E7955. [PMID: 33114763 DOI: 10.3390/ijms21217955] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
102 Chen YQ, Zhu WT, Lin CY, Yuan ZW, Li ZH, Yan PK. Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer. Int J Nanomedicine 2021;16:269-81. [PMID: 33469286 DOI: 10.2147/IJN.S270939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Ashrafizadeh M, Gholami MH, Mirzaei S, Zabolian A, Haddadi A, Farahani MV, Kashani SH, Hushmandi K, Najafi M, Zarrabi A, Ahn KS, Khan H. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis. Life Sci 2021;270:119006. [PMID: 33421521 DOI: 10.1016/j.lfs.2020.119006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
104 Li X, Wang J, Lin W, Yuan Q, Lu Y, Wang H, Chen Y, Chen L, Dai P, Long H, Li X. circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop. Mol Cancer 2022;21:135. [PMID: 35739524 DOI: 10.1186/s12943-022-01600-1] [Reference Citation Analysis]
105 Liu C, Ji L, Hu J, Zhao Y, Johnston LJ, Zhang X, Ma X. Functional Amino Acids and Autophagy: Diverse Signal Transduction and Application. Int J Mol Sci 2021;22:11427. [PMID: 34768858 DOI: 10.3390/ijms222111427] [Reference Citation Analysis]
106 Peng S, Cai J, Bao S. CMBs carrying PTX and CRISPR/Cas9 targeting C‑erbB‑2 plasmids interfere with endometrial cancer cells. Mol Med Rep 2021;24:830. [PMID: 34590151 DOI: 10.3892/mmr.2021.12470] [Reference Citation Analysis]
107 Horita Y, Kaira K, Kawasaki T, Mihara Y, Sakuramoto S, Yamaguchi S, Okamoto K, Ryozawa S, Kanai Y, Yasuda M, Hamaguchi T. Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms. In Vivo 2021;35:2425-32. [PMID: 34182526 DOI: 10.21873/invivo.12520] [Reference Citation Analysis]
108 Chen Y, Li Y, Huang L, Du Y, Gan F, Li Y, Yao Y. Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance. Oxid Med Cell Longev 2021;2021:6620306. [PMID: 33628367 DOI: 10.1155/2021/6620306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Luan M, Shi SS, Shi DB, Liu HT, Ma RR, Xu XQ, Sun YJ, Gao P. TIPRL, a Novel Tumor Suppressor, Suppresses Cell Migration, and Invasion Through Regulating AMPK/mTOR Signaling Pathway in Gastric Cancer. Front Oncol 2020;10:1062. [PMID: 32719745 DOI: 10.3389/fonc.2020.01062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Yang C, Zhang W, Dong X, Fu C, Yuan J, Xu M, Liang Z, Qiu C, Xu C. A natural product solution to aging and aging-associated diseases. Pharmacol Ther 2020;216:107673. [PMID: 32926934 DOI: 10.1016/j.pharmthera.2020.107673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
111 Rose MM, Dhamodharan S, Revathidevi S, Chakkarappan SR, Mani JG, Shanmugam S, Nakaoka H, Inoue I, Murugan AK, Munirajan AK. High incidence of PI3K pathway gene mutations in South Indian cervical cancers. Cancer Genetics 2022. [DOI: 10.1016/j.cancergen.2022.05.002] [Reference Citation Analysis]
112 Evangelisti C, Chiarini F, Paganelli F, Marmiroli S, Martelli AM. Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer. Biochim Biophys Acta Mol Cell Res 2020;1867:118635. [PMID: 31884070 DOI: 10.1016/j.bbamcr.2019.118635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
113 Yu L, Wei J, Liu P. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol 2021:S1044-579X(21)00188-7. [PMID: 34175443 DOI: 10.1016/j.semcancer.2021.06.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
114 Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. J Exp Clin Cancer Res. 2020;39:4. [PMID: 31898515 DOI: 10.1186/s13046-019-1512-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 18.0] [Reference Citation Analysis]